Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By boosting these https://kallumlufh450665.blogozz.com/35221319/tirzepatide-a-promising-new-treatment-for-obesity